http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104651521-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6809 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6844 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
filingDate | 2012-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104651521-B |
titleOfInvention | Plasma microRNA for early colorectal cancer detection |
abstract | The present invention relates generally to the field of colorectal cancer detection, and more particularly to plasma micrornas for early colorectal cancer detection. In particular, the invention includes methods, kits and biomarkers for diagnosing or detecting colorectal neoplasms in a human subject. The present invention provides a method for diagnosing or detecting a colorectal tumor in a human subject, comprising the steps of: obtaining one or more biological samples from a subject suspected of having a colorectal tumor; measuring the overall expression pattern or level of one or more micrornas obtained from one or more biological samples of the subject; and comparing the overall expression pattern of the one or more micrornas from the biological sample of the subject suspected of having a colorectal neoplasm to the overall expression pattern of the one or more micrornas from a biological sample of a normal subject, wherein the normal subject is a healthy subject not having a colorectal neoplasm, wherein overexpression of a combination of miR19a and miR19b, or miR19a and miR19b and miR15b is indicative of colorectal cancer. |
priorityDate | 2011-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 140.